Solmedx is a biomedical company engaged in the development of medical devices to assist in patient monitoring. The company designed the Immunogram™ Analyzer (patents pending), a tool for measuring ROX™ Reserve Oxygen and BOX™ Booster Oxygen.
Solmedx is a division of Air & Water Solutions, Inc. Founded in 1979, A&WS designed a complete line of CAP™ Clean Air Plants, biological air and water cleaning systems.
Solmedx is a privately held company headed by Dr. Sam Sofer. The company's home office is located in Nutley, New Jersey.
Exciting New Developments:
A Rutgers multi-center clinical study on Pain and ROX levels is currently
underway. At present we are seeking volunteers and patients for our clinical study on
the relationship of pain and ROX levels. The purpose of this Rutgers multi-center study
is to create norms for patients suffering from pain associated with chronic disease. If
you would like more information or are interested in volunteering for this study, click
here.
Planned future clinical studies are based on the following hypotheses:
ALS: Imbalanced ROX at the motor neuron leads to oxidative damage to the motor
neuron and surrounding tissue.
Alzheimer’s, Huntington’s, MS, and other neurodegenerative diseases: Imbalanced
ROX, for nervous system operation and signaling, leads to oxidative damage of nerve
tissue and surrounding tissue.
Cancer: A tumor cannot be contained if there is insufficient ROX. A cancer patient with
sufficient ROX can prevent a tumor from spreading by destroying any metastasized
cancer cells.
Complex Regional Pain Syndrome (CRPS): Out of balance ROX allows free radicals to
send unexplained pain signals to the brain.
Diabetes: If not enough ROX is delivered for glucose to be converted to energy, more
insulin will be required to control a person’s sugar level.
HIV/AIDs: When a T-cell recognizes a virus, it recruits a critical mass of ROX to destroy
the virus. Insufficient ROX leads to the premature release of oxygen, destroying T-cells
and surrounding tissues.
Parkinson’s Disease: Only about 30% of people with the gene for Parkinson’s Disease
(PD) actually get the disease. If less than a critical mass of ROX exists, radicals will be
released in the brain and the surrounding tissues, resulting in widespread damage and
causing a chain of events that leads to PD.
Rheumatoid Arthritis (RA) and other auto-immune diseases: Insufficient ROX allows for
the indiscriminate spread of radical oxygen species, thus damaging surrounding tissues.
Solmedx can be found online under the following tags: interferon treatment, patient blood samples,ROX (reservoir oxygen capacity), Cancer, innate immune viability,AIDs, BOX, blood cell oxygen capacity,
adaptive immune system strength,proper medication dosage, clinical studies,Hepatitis C, Diabetes, patient injury and drug toxicity Alzheimer's, ALS,
and other neurodegenerative diseases; Cancer; Diabetes; HIV/AIDS, Huntington's
Disease, Parkinson's Disease (PD), Rheumatoid Arthritis (RA) and other auto-immune
diseases; and Complex Regional Pain Syndrome (CRPS)]
